Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-5 (1999-2004)

被引:22
作者
Inoue, Matsuhisa [1 ]
Farrell, David J. [2 ]
Kaneko, Kenichi
Akizawa, Kouji [3 ]
Fujita, Shinichi [4 ]
Kaku, Mitsuo [5 ]
Igari, Jun [6 ]
Yamaguchi, Keizo [7 ]
Yamanaka, Kiyoharu [8 ]
Murase, Mitsuharu [9 ]
Asari, Seishi [10 ]
Hirakata, Yoichi [11 ]
Baba, Hisashi [8 ]
Itaha, Hideyuki [12 ]
机构
[1] Kitasato Univ, Sch Med, Dept Microbiol, Kanagawa 2288555, Japan
[2] GR Micro, London, England
[3] Hokkaido Univ, Sapporo, Hokkaido, Japan
[4] Kanazawa Univ, Kanazawa, Ishikawa, Japan
[5] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan
[6] Juntendo Univ, Sch Med, Tokyo 113, Japan
[7] Toho Univ, Sch Med, Tokyo, Japan
[8] Nagoya Univ, Sch Med, Nagoya, Aichi 466, Japan
[9] Ehime Univ, Sch Med, Matsuyama, Ehime 790, Japan
[10] Osaka Univ Hosp, Osaka 553, Japan
[11] Nagasaki Univ, Sch Med, Nagasaki 852, Japan
[12] Hiroshima Univ, Sch Med, Hiroshima, Japan
关键词
D O I
10.1089/mdr.2008.0806
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Susceptibility to a range of antimicrobial agents was determined among isolates of Streptococcus pneumoniae, Streptococcus pyogenes, and Haemophilus influenzae collected in 12 centers throughout Japan during years 1-5 (the respiratory seasons of 1999-2004) of the longitudinal Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin study. The most frequent source of isolates of S. pneumoniae was from patients with community-acquired pneumonia (CAP) (25.3%). Reduced susceptibility to penicillin or erythromycin resistance was common among S. pneumoniae isolates (30.9-44.5% and 77.2-81.9%, respectively). The macrolide MIC(50) for S. pneumoniae was 128 mu g/ml (azithromycin and erythromycin) and E! 64 mu g/ml (clarithromycin). The erm(B) genotype accounted for the most erythromycin-resistant isolates in each study year. H. influenzae isolates were most commonly derived from patients with CAP (26.2%). The proportion of H. influenzae isolates that were P-lactamase positive ranged between 4.3% and 9.7%. The prevalence of P-lactamase-negative ampicillin-resistant isolates increased from 0.4% to 2.6% between years I and 4 then to 19.7% in year 5. S. pyogenes isolates were highly susceptible to most antimicrobial agents except macrolides and tetracycline. Telithromycin was highly active against all three pathogens examined throughout the study.
引用
收藏
页码:109 / 117
页数:9
相关论文
共 17 条
[1]  
[Anonymous], 2007, Document M100-S17
[2]  
Clinical and Laboratory Standards Institute, 2006, M07A7 CLSI
[3]   Management of acute bacterial rhinosinusitis: current issues and future perspectives [J].
Desrosiers, M ;
Klossek, JM ;
Benninger, M .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (02) :190-200
[4]   Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance [J].
Farrell, DJ ;
Jenkins, SG ;
Brown, SD ;
Patel, M ;
Lavin, BS ;
Klugman, KP .
EMERGING INFECTIOUS DISEASES, 2005, 11 (06) :851-858
[5]   Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study [J].
Farrell, DJ ;
Morrissey, I ;
Bakker, S ;
Felmingham, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 :39-47
[6]   Detection of macrolide resistance mechanisms in Streptococcus pneumonide and Streptococcus pyogenes using a multiplex rapid cycle PCR with microwell-format probe hybridization [J].
Farrell, DJ ;
Morrissey, I ;
Bakker, S ;
Felmingham, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (04) :541-544
[7]   The Alexander Project 1996-1997:: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections [J].
Felmingham, D ;
Grüneberg, RN .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (02) :191-203
[8]   The need for antimicrobial resistance surveillance [J].
Felmingham, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 :1-7
[9]   Streptococcus pneumoniae and community-acquired pneumonia:: A cause for concern [J].
File, TM .
AMERICAN JOURNAL OF MEDICINE, 2004, 117 :39-50
[10]   Community-acquired lower respiratory tract infections - Etiology and treatment [J].
Guthrie, R .
CHEST, 2001, 120 (06) :2021-2034